SBF AG (CY1K.DE) Fundamental Analysis & Valuation

FRA:CY1K • DE000A2AAE22

4.3 EUR
-0.02 (-0.46%)
Last: Mar 10, 2026, 07:00 PM

This CY1K.DE fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to CY1K. CY1K was compared to 73 industry peers in the Electrical Equipment industry. While CY1K seems to be doing ok healthwise, there are quite some concerns on its profitability. While showing a medium growth rate, CY1K is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

1

1. CY1K.DE Profitability Analysis

1.1 Basic Checks

  • In the past year CY1K has reported negative net income.
  • CY1K had a negative operating cash flow in the past year.
  • The reported net income has been mixed in the past 5 years: CY1K reported negative net income in multiple years.
  • The reported operating cash flow has been mixed in the past 5 years: CY1K reported negative operating cash flow in multiple years.
CY1K.DE Yearly Net Income VS EBIT VS OCF VS FCFCY1K.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2M -2M 4M -4M -6M -8M

1.2 Ratios

  • CY1K has a Return On Assets of -4.03%. This is in the lower half of the industry: CY1K underperforms 65.75% of its industry peers.
  • CY1K has a Return On Equity of -6.32%. This is in the lower half of the industry: CY1K underperforms 60.27% of its industry peers.
Industry RankSector Rank
ROA -4.03%
ROE -6.32%
ROIC N/A
ROA(3y)-4.25%
ROA(5y)1.07%
ROE(3y)-6.03%
ROE(5y)2.13%
ROIC(3y)N/A
ROIC(5y)N/A
CY1K.DE Yearly ROA, ROE, ROICCY1K.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20

1.3 Margins

  • CY1K's Gross Margin of 47.99% is fine compared to the rest of the industry. CY1K outperforms 73.97% of its industry peers.
  • In the last couple of years the Gross Margin of CY1K has declined.
  • CY1K does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 47.99%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.52%
GM growth 5Y-3.06%
CY1K.DE Yearly Profit, Operating, Gross MarginsCY1K.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40

6

2. CY1K.DE Health Analysis

2.1 Basic Checks

  • CY1K does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • The number of shares outstanding for CY1K remains at a similar level compared to 1 year ago.
  • The number of shares outstanding for CY1K has been increased compared to 5 years ago.
  • CY1K has a better debt/assets ratio than last year.
CY1K.DE Yearly Shares OutstandingCY1K.DE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M
CY1K.DE Yearly Total Debt VS Total AssetsCY1K.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M

2.2 Solvency

  • An Altman-Z score of 3.21 indicates that CY1K is not in any danger for bankruptcy at the moment.
  • CY1K has a Altman-Z score of 3.21. This is in the better half of the industry: CY1K outperforms 68.49% of its industry peers.
  • A Debt/Equity ratio of 0.00 indicates that CY1K is not too dependend on debt financing.
  • Looking at the Debt to Equity ratio, with a value of 0.00, CY1K belongs to the top of the industry, outperforming 95.89% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 3.21
ROIC/WACCN/A
WACC8.81%
CY1K.DE Yearly LT Debt VS Equity VS FCFCY1K.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M 20M 30M

2.3 Liquidity

  • A Current Ratio of 5.56 indicates that CY1K has no problem at all paying its short term obligations.
  • The Current ratio of CY1K (5.56) is better than 94.52% of its industry peers.
  • CY1K has a Quick Ratio of 2.04. This indicates that CY1K is financially healthy and has no problem in meeting its short term obligations.
  • With an excellent Quick ratio value of 2.04, CY1K belongs to the best of the industry, outperforming 84.93% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 5.56
Quick Ratio 2.04
CY1K.DE Yearly Current Assets VS Current LiabilitesCY1K.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M

5

3. CY1K.DE Growth Analysis

3.1 Past

  • CY1K shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 40.00%, which is quite impressive.
  • Looking at the last year, CY1K shows a very strong growth in Revenue. The Revenue has grown by 38.99%.
  • CY1K shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 22.84% yearly.
EPS 1Y (TTM)40%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%65.52%
Revenue 1Y (TTM)38.99%
Revenue growth 3Y14.83%
Revenue growth 5Y22.84%
Sales Q2Q%42.09%

3.2 Future

  • CY1K is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 63.55% yearly.
  • The Revenue is expected to grow by 6.51% on average over the next years.
EPS Next Y83.33%
EPS Next 2Y76.78%
EPS Next 3Y63.55%
EPS Next 5YN/A
Revenue Next Year-15.38%
Revenue Next 2Y-3.42%
Revenue Next 3Y2%
Revenue Next 5Y6.51%

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
CY1K.DE Yearly Revenue VS EstimatesCY1K.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 20M 40M 60M
CY1K.DE Yearly EPS VS EstimatesCY1K.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 0.1 -0.1 0.2 0.3 0.4

1

4. CY1K.DE Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for CY1K. In the last year negative earnings were reported.
  • Also next year CY1K is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
CY1K.DE Price Earnings VS Forward Price EarningsCY1K.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 -50 -100 -150 -200

4.2 Price Multiples

  • CY1K's Enterprise Value to EBITDA ratio is a bit more expensive when compared to the industry. CY1K is more expensive than 67.12% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 109.83
CY1K.DE Per share dataCY1K.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2 3 4

4.3 Compensation for Growth

  • CY1K's earnings are expected to grow with 63.55% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y76.78%
EPS Next 3Y63.55%

0

5. CY1K.DE Dividend Analysis

5.1 Amount

  • No dividends for CY1K!.
Industry RankSector Rank
Dividend Yield 0%

CY1K.DE Fundamentals: All Metrics, Ratios and Statistics

SBF AG

FRA:CY1K (3/10/2026, 7:00:00 PM)

4.3

-0.02 (-0.46%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryElectrical Equipment
Earnings (Last)10-15
Earnings (Next)N/A
Inst Owners11.05%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap41.75M
Revenue(TTM)47.20M
Net Income(TTM)-1.99M
Analysts86.67
Price Target9.27 (115.58%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-1.45%
PT rev (3m)2.49%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-100%
EPS NY rev (3m)-300%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-8.35%
Revenue NY rev (3m)-12.08%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.88
P/FCF N/A
P/OCF N/A
P/B 1.33
P/tB 1.33
EV/EBITDA 109.83
EPS(TTM)-0.21
EYN/A
EPS(NY)-0.02
Fwd EYN/A
FCF(TTM)-0.28
FCFYN/A
OCF(TTM)-0.17
OCFYN/A
SpS4.86
BVpS3.24
TBVpS3.24
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -4.03%
ROE -6.32%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 47.99%
FCFM N/A
ROA(3y)-4.25%
ROA(5y)1.07%
ROE(3y)-6.03%
ROE(5y)2.13%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.52%
GM growth 5Y-3.06%
F-Score5
Asset Turnover0.96
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA 0.02
Cap/Depr 68.48%
Cap/Sales 2.16%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 5.56
Quick Ratio 2.04
Altman-Z 3.21
F-Score5
WACC8.81%
ROIC/WACCN/A
Cap/Depr(3y)99.31%
Cap/Depr(5y)148.34%
Cap/Sales(3y)5.49%
Cap/Sales(5y)6.81%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)40%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%65.52%
EPS Next Y83.33%
EPS Next 2Y76.78%
EPS Next 3Y63.55%
EPS Next 5YN/A
Revenue 1Y (TTM)38.99%
Revenue growth 3Y14.83%
Revenue growth 5Y22.84%
Sales Q2Q%42.09%
Revenue Next Year-15.38%
Revenue Next 2Y-3.42%
Revenue Next 3Y2%
Revenue Next 5Y6.51%
EBIT growth 1Y53.81%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year250.48%
EBIT Next 3Y121.61%
EBIT Next 5Y72.84%
FCF growth 1Y-112.55%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-343.31%
OCF growth 3YN/A
OCF growth 5YN/A

SBF AG / CY1K.DE FAQ

What is the ChartMill fundamental rating of SBF AG (CY1K.DE) stock?

ChartMill assigns a fundamental rating of 3 / 10 to CY1K.DE.


What is the valuation status of SBF AG (CY1K.DE) stock?

ChartMill assigns a valuation rating of 1 / 10 to SBF AG (CY1K.DE). This can be considered as Overvalued.


What is the profitability of CY1K stock?

SBF AG (CY1K.DE) has a profitability rating of 1 / 10.


Can you provide the financial health for CY1K stock?

The financial health rating of SBF AG (CY1K.DE) is 6 / 10.


Can you provide the expected EPS growth for CY1K stock?

The Earnings per Share (EPS) of SBF AG (CY1K.DE) is expected to grow by 83.33% in the next year.